PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment ...
The victim says he sent someone claiming to be from the El Paso County Sheriff's Office $15,000 in Bitcoin. HARRISONBURG, Va. (WHSV) - After a fire broke out in a James Madison University ...
An Arizona woman got a call about a missing rental car and was charged hundreds of dollars that landed in collections. Susan Campbell explains what went wrong. ASU is partnering with the Maricopa ...
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment ... “The longer we can keep patients from having severe symptoms from reoccurring improves ...
“The longer we can keep patients from having severe symptoms from reoccurring improves their overall prognosis over the course of their life,” he added. “I’d be interested to see if other ...
Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression ... “The longer we can keep patients from having severe symptoms from reoccurring improves ...
SINGAPORE – The deadly consequences of hoarding were highlighted after a fire in a Hougang flat killed three people on Jan 9. Neighbours had said the family living in the unit were hoarders.
Storm Éowyn will be a “dangerous, destructive” weather event and among the most severe storms Ireland has ever experienced, the chair of the National Emergency Co-ordination Group (NECG) ...
Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant depression. This marks a significant advancement in depression treatment ...
Johnson & Johnson's nasal spray received US FDA approval The nasal spray is used for the treatment of major depressive disorder The drug brought in sales of $780 million in 2024 The US Food and Drug ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results